BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25158817)

  • 21. Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression.
    Kim H; Yoo SB; Choe JY; Paik JH; Xu X; Nitta H; Zhang W; Grogan TM; Lee CT; Jheon S; Chung JH
    J Thorac Oncol; 2011 Aug; 6(8):1359-66. PubMed ID: 21587085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors.
    Griffin CA; Hawkins AL; Dvorak C; Henkle C; Ellingham T; Perlman EJ
    Cancer Res; 1999 Jun; 59(12):2776-80. PubMed ID: 10383129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of human herpesvirus-8 and Epstein-Barr virus in inflammatory myofibroblastic tumor with anaplastic large cell lymphoma kinase fusion gene.
    Yamamoto H; Kohashi K; Oda Y; Tamiya S; Takahashi Y; Kinoshita Y; Ishizawa S; Kubota M; Tsuneyoshi M
    Pathol Int; 2006 Oct; 56(10):584-90. PubMed ID: 16984614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drastic initial response and subsequent response to two ALK inhibitors in a patient with a highly aggressive ALK-rearranged inflammatory myofibroblastic tumor arising in the pleural cavity.
    Ono A; Murakami H; Serizawa M; Wakuda K; Kenmotsu H; Naito T; Taira T; Koh Y; Ohde Y; Nakajima T; Endo M; Takahashi T
    Lung Cancer; 2016 Sep; 99():151-4. PubMed ID: 27565932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An inflammatory myofibroblastic tumor in liver with ALK and RANBP2 gene rearrangement: combination of distinct morphologic, immunohistochemical, and genetic features.
    Chen ST; Lee JC
    Hum Pathol; 2008 Dec; 39(12):1854-8. PubMed ID: 18701132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory myofibroblastic tumour: a rare entity with wide differential diagnosis.
    Gilani SM; Kowalski PJ
    Pathologica; 2014 Mar; 106(1):1-6. PubMed ID: 24897773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of rearrangements and transcriptional up-regulation of ALK in FFPE lung cancer specimens using a novel, sensitive, quantitative reverse transcription polymerase chain reaction assay.
    Gruber K; Horn H; Kalla J; Fritz P; Rosenwald A; Kohlhäufl M; Friedel G; Schwab M; Ott G; Kalla C
    J Thorac Oncol; 2014 Mar; 9(3):307-15. PubMed ID: 24495999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous neoplasms showing EWSR1 rearrangement.
    Boland JM; Folpe AL
    Adv Anat Pathol; 2013 Mar; 20(2):75-85. PubMed ID: 23399793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ALK-rearranged Inflammatory Myofibroblastic Tumor of the Placenta, With Observations on Site of Origin.
    Schoolmeester JK; Sukov WR
    Int J Gynecol Pathol; 2017 May; 36(3):228-229. PubMed ID: 27636888
    [No Abstract]   [Full Text] [Related]  

  • 30. ALK-positive inflammatory myofibroblastic tumor of the abdomen with widespread microscopic multifocality.
    Lorenzi L; Cigognetti M; Medicina D; Pellegrini V; Balzarini P; Cestari R; Facchetti F
    Int J Surg Pathol; 2014 Oct; 22(7):640-4. PubMed ID: 24583837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor.
    Ma Z; Hill DA; Collins MH; Morris SW; Sumegi J; Zhou M; Zuppan C; Bridge JA
    Genes Chromosomes Cancer; 2003 May; 37(1):98-105. PubMed ID: 12661011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical fibrous histiocytoma of the skin with CD30 and p80/ALK1 positivity and ALK gene rearrangement.
    Szablewski V; Laurent-Roussel S; Rethers L; Rommel A; Van Eeckhout P; Camboni A; Willocz P; Copie-Bergman C; Ortonne N
    J Cutan Pathol; 2014 Sep; 41(9):715-9. PubMed ID: 24666231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of ALK rearrangement by immunohistochemistry in lung adenocarcinoma and the identification of a novel EML4-ALK variant.
    To KF; Tong JH; Yeung KS; Lung RW; Law PP; Chau SL; Kang W; Tong CY; Chow C; Chan AW; Leung LK; Mok TS
    J Thorac Oncol; 2013 Jul; 8(7):883-91. PubMed ID: 23625156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor.
    Debiec-Rychter M; Marynen P; Hagemeijer A; Pauwels P
    Genes Chromosomes Cancer; 2003 Oct; 38(2):187-90. PubMed ID: 12939746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory myofibroblastic tumor of the larynx with anaplastic lymphoma kinase (ALK) protein overexpression. A case report.
    Bellezza G; Cavaliere A; Del Sordo R; Sidoni A
    Tumori; 2006; 92(5):449-51. PubMed ID: 17168442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of ALK expression in different human cancer types.
    Tennstedt P; Strobel G; Bölch C; Grob T; Minner S; Masser S; Simon R
    J Clin Pathol; 2014 Jun; 67(6):477-81. PubMed ID: 24478382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas.
    Boland JM; Erdogan S; Vasmatzis G; Yang P; Tillmans LS; Johnson MR; Wang X; Peterson LM; Halling KC; Oliveira AM; Aubry MC; Yi ES
    Hum Pathol; 2009 Aug; 40(8):1152-8. PubMed ID: 19386350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anaplastic lymphoma kinase protein expression, genetic abnormalities, and phosphorylation in soft tissue tumors: Phosphorylation is associated with recurrent metastasis.
    Ishibashi Y; Miyoshi H; Hiraoka K; Arakawa F; Haraguchi T; Nakashima S; Hashiguchi T; Shoda T; Hamada T; Okawa T; Higuchi F; Shiba N; Nagata K; Ohshima K
    Oncol Rep; 2015 Apr; 33(4):1667-74. PubMed ID: 25683346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ALK rearrangement in a large series of consecutive non-small cell lung cancers: comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment.
    Alì G; Proietti A; Pelliccioni S; Niccoli C; Lupi C; Sensi E; Giannini R; Borrelli N; Menghi M; Chella A; Ribechini A; Cappuzzo F; Melfi F; Lucchi M; Mussi A; Fontanini G
    Arch Pathol Lab Med; 2014 Nov; 138(11):1449-58. PubMed ID: 24885803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-grade myofibroblastic proliferations of the urinary bladder.
    Alquati S; Gira FA; Bartoli V; Contini S; Corradi D
    Arch Pathol Lab Med; 2013 Aug; 137(8):1117-28. PubMed ID: 23899070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.